Prognostic role of angiogenesis in colorectal cancer

Anticancer Research

Volumn 21, Issue 6 B, 2001, Pages 4349-4353

  Papamichael, D ^a  

^a Bank of Cyprus Group Oncology Centre   (Cyprus)

Author keywords

Angiogenesis; Colorectal cancer; Prognosis

Indexed keywords

ANGIOGENIC FACTOR; ANTINEOPLASTIC AGENT; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; DENSITY; DRUG INDUCED DISEASE; HUMAN; METASTASIS; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR GROWTH;

COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; THYMIDINE PHOSPHORYLASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035574123     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Angiogenesis
2. Growth and metastasis of tumour in organ culture
3. Induction of angiogenesis during the transition of hyperplasia to neoplasia
4. Quantitative relationships of intravascular tumour cells, tumour vessel, and pulmonary metastasis following tumour implantation
5. Angiogenesis and breast cancer
6. The prognostic significance of tumour vascularity in intermediate thickness (0.76-4.00mm thick) skin melanoma
7. Biology of tumour progression in human melanocytes
8. Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma
9. Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases in breast cancer
10. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma
11. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma
12. Relation of neovascularzation to metastasis of non-small cell lung cancer
13. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma
14. Angiogenesis as an unfavourable prognostic factor in human colorectal carcinoma
15. Microvascular quantification and its possible relation with liver metastasis in colorectal cancer
16. Tumor angiogenesis as predictor of recurrence and survival in patients with node-negative colon cancer
17. Tumour angiogenesis and rectal carcinoma
18. Tumor angiogenesis in primary and metastatic colorectal cancers
19. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
20. Vessel counts and expression of vascular endothelial growth factors as prognostic factors in nodenegative colon cancer
21. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer
22. The classification of cancer of the rectum
23. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells
24. Regulation of VEGF/VPF expression in tumour cells: Consequenses for tumor growth and metastasis
25. Clinical applications of angiogenic growth factors and their inhibitors
26. Extent of vascularization as a prognostic indicator in thin (<0.76mm) malignant melanomas
27. Demonstration and characterization of the angiogenic properties of cervical dysplasia
28. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
29. Angiogenesis in colorectal tumors: Microvessel quantitation in adenomas and carcinomas with clinicopathological correlations
30. Tumour angiogenesis as a predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence
31. Combined role of angiogenesis, bcl-2 and p53 expression in the prognosis of colorectal cancer
32. Is tumour angiogenesis a prognostic factor in patients with colorectal cancer and no involved nodes?
33. VEGF/VPF: The angiogenesis factor found?
34. Vascular permeability factor, an endothelial cell mitogen related to PDGF
35. Vascular endothelial growth factor is a secreted angiogenic mitogen
36. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
37. The vascular endothelial growth factor family, identification of fourth molecular species and characterization of alternative splicing of RNA
38. Tumour cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
39. Purification and NH-2 terminal amino acid sequence of guinea pig tumour secreted vascular pen-neability factor
40. Vascular endothelial growth factor (VEGF) expression and alternate splicing in non-metastatic and metastatic human colon cancer cell line
41. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
42. Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma
43. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis
44. Vascular endothelial growth factor in human breast cancer: Correlation with disease-free survival
45. Prognostic value of vascular endothelial growth factor and its receptor Fit-I in squarnous cell lung cancer
46. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
47. Implication of vascular endothelial growth factor and p53 status for angiogenesis in non-invasive colorectal carcinoma
48. Prognostic value of angiogenesis in gastrointestinal turnours
49. Predictive value of vascular endothelial growth factor for metastasis and prognosis of human colorectal cancer
50. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer
51. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer
52. Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma
53. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma
54. Pre-operative serum vascular endothelial groth factor can select patients for adjuvant treatment after curative resection in colorectal cancer
55. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumour angiogenesis and macrophage infiltration in colorectal cancer
56. Thymidine phosphorylase expression is related to response in patients treated with 5-fluorouracil
57. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal cancer is associated with non-response to 5-fluorouracil
58. Colorectal tumours responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
59. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor proliferation markers in colorectal cancer
60. Invasion of human colorectal carcinoma cells is promoted by endogenous basic fibroblast growth factor
61. Quantitative analysis of basic fibriblast growth factor and vascular endothelial growth factor in human colorectal cancer
62. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume